Alison R. Sehgal

6.5k citations
52 papers · 1.1k indexed · h-index 13
  • Hematology top 5%
    • Acute Myeloid Leukemia Research 15
    • Hematopoietic Stem Cell Transplantation 9
  • Oncology top 5%
    • CAR-T cell therapy research 29
    • Cancer Immunotherapy and Biomarkers 7
    • Neutropenia and Cancer Infections 5
  • Genetics top 10%
    • Chronic Lymphocytic Leukemia Research 5
  • Immunology top 10%
    • Biosimilars and Bioanalytical Methods 7
    • Lymphoma Diagnosis and Treatment 16

Alison R. Sehgal

47 papers receiving 1.1k citations

Peers

Alison R. Sehgal
Comparison fields: 5 of 70
  • Hematology 326
  • Oncology 633
  • Genetics 143
  • Immunology 227
  • Pathology and Forensic Medicine 174
Replace Benoît Tessoulin with:
Benoît Tessoulin France
Kathleen Dorritie United States
Connie Lee Batlevi United States
Quanshun Wang China
Zhengming Jin China
Zaid Al‐Kadhimi United States
Zeba N. Singh United States
Matteo Da Vià Italy
Paolo Alberto Paciucci United States
Irene Pizzitola Italy
Alison R. Sehgal relative to Benoît Tessoulin France Benoît Tessoulin's profile →
Citations per field
00.5×1.6×
Benoît Tessoulin · 1×
Citations per year

Countries citing papers authored by Alison R. Sehgal

Since Specialization
Citations

This map shows the geographic impact of Alison R. Sehgal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison R. Sehgal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison R. Sehgal more than expected).

Fields of papers citing papers by Alison R. Sehgal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison R. Sehgal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison R. Sehgal. The network helps show where Alison R. Sehgal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alison R. Sehgal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison R. Sehgal Line = papers co-authored together Alison R. Sehgal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20241
3 20236
4 20230
5 202140
6 20214
7 202011
8 20204
9 20206
10 201989
11 201810
12 20161
13 20169
14 201620
15 201539
16 20151
17 201551
18 2014193
19 201475
20 20146

About Alison R. Sehgal

Alison R. Sehgal is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (29 papers), Lymphoma Diagnosis and Treatment (16 papers), Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Biosimilars and Bioanalytical Methods (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Hematology (326 citations), Oncology (633 citations) and Genetics (143 citations). Alison R. Sehgal has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Michael Boyiadzis, Annie Im, Martin Carroll, Daniel E. Johnson, Ayalew Tefferi, B. Douglas Smith, Theresa L. Whiteside, David G. Maloney, Charalambos Andreadis and Jeremy S. Abramson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026